The influence of cognitive impairment on driving performance in multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To examine the influence of impaired cognitive processing on measures of driving skills in persons with MS.
Methods: Twenty-eight subjects with documented MS were divided into two groups—with [MS(+), n = 13] and without [MS(−), n = 15] cognitive impairment—based on neuropsychological performance. Healthy control (HC) subjects (n = 17) matched on age and driving experience were also studied. Driving-related skills were compared between the groups based on performance on two computerized driving tests: the Useful Field of Vision (UFOV) and the Neurocognitive Driving Test (NDT).
Results: The MS(+) group performed significantly worse than both the MS(−) and HC groups in the latency to perform several driving-specific functions on the NDT, but no overall group differences were observed in actual errors on the NDT. On the UFOV, when compared to MS(−) and HC subjects, the MS(+) group demonstrated poorer performance on two of the three subtests. Additionally, a significantly higher percentage of MS(+) individuals were rated within the high risk (probability of crash involvement) category, relative to the MS(−) and HC groups.
Conclusions: Cognitive impairment can negatively affect driving-related skills in persons with MS and should be considered in the determination of driving ability.
- Received July 19, 2000.
- Accepted January 9, 2001.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Gray matter microglial activation in relapsing vs progressive MSA [F-18]PBR06-PET studyTarun Singhal, Kelsey O'Connor, Shipra Dubey et al.Neurology: Neuroimmunology & Neuroinflammation, July 01, 2019 -
Articles
Fatigue and declines in cognitive functioning in multiple sclerosisLauren B. Krupp, Leigh E. Elkins et al.Neurology, October 10, 2000 -
Article
Cortical topological network changes following optic neuritisYael Backner, Ido Ben-Shalom, Joseph Kuchling et al.Neurology: Neuroimmunology & Neuroinflammation, March 02, 2020 -
Article
Cognitive impairment differs between primary progressive and relapsing-remitting MSAurélie Ruet, Mathilde Deloire, Julie Charré-Morin et al.Neurology, March 20, 2013